首页> 中文期刊> 《中国医药导报》 >血清C1q、超敏C反应蛋白与冠状动脉粥样硬化性心脏病的相关性研究

血清C1q、超敏C反应蛋白与冠状动脉粥样硬化性心脏病的相关性研究

         

摘要

Objective To explore the correlation between serum C1q,hypersensitive C-reactive protein(hs-CRP) and coronary atherosclerotic heart disease(CHD).Methods From October 2016 to April 2017,406 clinical data of patients treated in the Department of Cardiology,Dongfeng General Hospital,Hubei University of Medicine were analyzed retrospectively and divided into the control group (200 cases) and the CHD group (206 cases) according to the history of percutaneous coronary intervention coronary angiography or whether the coronary artery stenosis was greater than 50% by coronary angiography.The levels of C1q and hs-CRP were compared between the two groups.The risk factors of CHD were analyzed by Logistic regression analysis.Results The serum C1q in the CHD group was lower than that of control group,and the hs-CRP in the CHD group was higher than that of control group,with statistically significant differences (P < 0.05).Logistic regression analysis indicated that in the coronary heart disease group the age (OR =1.036,95%CI =1.009-1.064,P < 0.05),diabetes (OR =4.629,95%CI =2.159-9.924,P < 0.05),LDL-C (OR =2.965,95%CI =1.286-6.835,P < 0.05),Glu (OR =1.033,95%CI =1.246-1.856,P < 0.05),hs-CRP (OR =1.509,95%CI =1.225-1.859,P < 0.05) were the risk factors for CHD and the C1q (OR =0.991,95%CI =0.983-0.998,P < 0.05) was the protective factor.Conclusion Serum C1q is the protective factor and hs-CRP is the risk factor in CHD and both can be used as clinically reliable diagnosis and evaluation index for CHD.%目的 探讨血清C1q、超敏CRP(hs-CRP)水平与冠状动脉粥样硬化性心脏病(CHD)的相关性.方法 回顾性分析2016年10月~2017年4月在湖北医药学院附属东风总医院心内科406例患者的临床资料,根据是否有冠状动脉介入手术史或冠脉造影检查发现冠脉狭窄程度是否≥50%分为对照组(200例)和冠心病组(206例).比较两组患者C1q、hs-CRP水平.采用Logistic回归分析对CHD的危险因素进行分析.结果 冠心病组血清C1q水平低于对照组,血清hs-CRP水平高于对照组,差异有统计学意义(P<0.05).Logistic多因素回归分析显示,年龄(OR=1.036,95% CI =1.009~1.064,P<0.05)、糖尿病(OR=4.629,95% CI=2.159~9.924,P<0.05)、LDL-C(OR=2.965,95%CI=1.286~6.835,P< 0.05),Glu(OR=1.033,95% CI=1.246~1.856,P< 0.05),hs-CRP(OR=1.509,95% CI=1.225~1.859,P<0.05)是CHD的危险因素,C1q(OR=0.991,95% CI=0.983~0.998,P<0.05)是CHD的保护因素.结论 血清C1q是CHD的保护因素,hs-CRP是CHD的危险因素,二者可以作为临床上较可靠的CHD诊断、评估预测指标.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号